April 2026 FDA Recall Enalapril Maleate by Jb Chemicals And Pharmaceuticals Ltd
D-0520-2026 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Jb Chemicals And Pharmaceuticals Ltd on April 23, 2026 for the product Enalapril Maleate. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0520-2026

Reason for Recall
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
Initiated
04-23-2026
Reported
05-13-2026
Quantity
675 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
JB Chemicals and Pharmaceuticals Ltd
Nationwide in the USA
Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.

Batch or Lot Expiration Information

Lot# : GEH25023, Expires: 6/30/2027